Your browser doesn't support javascript.
loading
Clusterin glycopeptide variant characterization reveals significant site-specific glycan changes in the plasma of clear cell renal cell carcinoma.
Gbormittah, Francisca O; Bones, Jonathan; Hincapie, Marina; Tousi, Fateme; Hancock, William S; Iliopoulos, Othon.
Affiliation
  • Gbormittah FO; †Barnett Institute and Department of Chemistry and Chemical Biology, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115, United States.
  • Bones J; §NIBRT-The National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland.
  • Hincapie M; ∥Genzyme, a Sanofi Company, 45 New York Avenue, Framingham, Massachusetts 01701, United States.
  • Tousi F; †Barnett Institute and Department of Chemistry and Chemical Biology, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115, United States.
  • Hancock WS; †Barnett Institute and Department of Chemistry and Chemical Biology, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115, United States.
  • Iliopoulos O; ⊥Center for Cancer Research at Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts 02129, United States.
J Proteome Res ; 14(6): 2425-36, 2015 Jun 05.
Article in En | MEDLINE | ID: mdl-25855029

Full text: 1 Database: MEDLINE Main subject: Polysaccharides / Glycopeptides / Carcinoma, Renal Cell / Clusterin / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Proteome Res Journal subject: BIOQUIMICA Year: 2015 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Polysaccharides / Glycopeptides / Carcinoma, Renal Cell / Clusterin / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Proteome Res Journal subject: BIOQUIMICA Year: 2015 Type: Article Affiliation country: United States